Expression and Subcellular Targeting of Human Complement Factor C5a in Nicotiana species

被引:19
|
作者
Nausch, Henrik [1 ]
Mischofsky, Heike [1 ]
Koslowski, Roswitha [2 ]
Meyer, Udo [2 ]
Broer, Inge [1 ]
Huckauf, Jana [1 ]
机构
[1] Univ Rostock, Agr & Environm Fac, Dept Agrobiotechnol, Rostock, Germany
[2] Bioserv GmbH, Rostock, Germany
来源
PLOS ONE | 2012年 / 7卷 / 12期
关键词
PLANT-MADE PHARMACEUTICALS; HIGH-YIELD PRODUCTION; HETEROLOGOUS PROTEINS; ENDOPLASMIC-RETICULUM; MONOCLONAL-ANTIBODY; GENE-EXPRESSION; N-GLYCOSYLATION; SEVERE SEPSIS; TOBACCO; STRATEGIES;
D O I
10.1371/journal.pone.0053023
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
We evaluated transgenic tobacco plants as an alternative to Escherichia coli for the production of recombinant human complement factor 5a (C5a). C5a has not been expressed in plants before and is highly unstable in vivo in its native form, so it was necessary to establish the most suitable subcellular targeting strategy. We used the strong and constitutive CaMV 35S promoter to drive transgene expression and compared three different subcellular compartments. The yields of C5a in the T-0 transgenic plants were low in terms of the proportion of total soluble protein (TSP) when targeted to the apoplast (0.0002% TSP) or endoplasmic reticulum (0.0003% TSP) but was one order of magnitude higher when targeted to the vacuole (0.001% TSP). The yields could be increased by conventional breeding (up to 0.014% TSP in the T-2 generation). C5a accumulated to the same level in seeds and leaves when targeted to the apoplast but was up to 1.7-fold more abundant in the seeds when targeted to the ER or vacuole, although this difference was less striking in the better-performing lines. When yields were calculated as an amount per gram fresh weight of transgenic plant tissue, the vacuole targeting strategy was clearly more efficient in seeds, reaching 35.8 mu g C5a per gram of fresh seed weight compared to 10.62 mu g C5a per gram fresh weight of leaves. Transient expression of C5aER and C5aVac in N. benthamiana, using MagnICON vectors, reached up to 0.2% and 0.7% of TSP, respectively, but was accompanied by cytotoxic effects and induced leaf senescence. Western blot of the plant extracts revealed a band matching the corresponding glycosylated native protein and the bioassay demonstrated that recombinant C5a was biologically active.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Expression of complement C5A anaphylatoxin receptor (C5AR) in human diseased kidney.
    Abe, K
    Miyazaki, M
    Koji, T
    Furusu, A
    Ozono, Y
    Harada, T
    Nakane, PK
    Suzuki, D
    Nomoto, Y
    Sakai, H
    Kohno, S
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A2470 - A2470
  • [2] HIGH-LEVEL EXPRESSION OF A GENE ENCODING THE HUMAN-COMPLEMENT FACTOR C5A IN ESCHERICHIA-COLI
    MANDECKI, W
    POWELL, BS
    MOLLISON, KW
    CARTER, GW
    FOX, JL
    GENE, 1986, 43 (1-2) : 131 - 138
  • [3] MODULATION OF THE ACTIVITY OF COMPLEMENT C5A BY CHEMOTACTIC FACTOR INACTIVATOR
    RASMUSSEN, JK
    CLAYTON, ME
    RENNARD, SI
    ROBBINS, RA
    CLINICAL RESEARCH, 1985, 33 (04): : A857 - A857
  • [4] Targeting Complement C5a Receptor 1 for the Treatment of Immunosuppression in Sepsis
    Sommerfeld, Oliver
    Medyukhina, Anna
    Neugebauer, Sophie
    Ghait, Mohamed
    Ulferts, Svenja
    Lupp, Amelie
    Koning, Rainer
    Wetzker, Reinhard
    Schulz, Stefan
    Figge, Marc Thilo
    Bauer, Michael
    Press, Adrian T.
    MOLECULAR THERAPY, 2021, 29 (01) : 338 - 346
  • [5] Complement factor C5a induces atherosclerotic plaque disruptions
    Wezel, Anouk
    de Vries, Margreet R.
    Lagraauw, H. Maxime
    Foks, Amanda C.
    Kuiper, Johan
    Quax, Paul H. A.
    Bot, Ilze
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2014, 18 (10) : 2020 - 2030
  • [6] METABOLIC BEHAVIOR OF HUMAN C5A AND C5A DES ARG COMPLEMENT FRAGMENTS IN NORMAL RABBITS
    WEBSTER, RO
    LARSEN, GL
    FEDERATION PROCEEDINGS, 1980, 39 (03) : 701 - 701
  • [7] Effects of complement 5a (C5a) and tumor necrosis factor on C5a receptors of neuroblastoma cells.
    Farkas, J
    Buranyi, L
    Yamamoto, T
    Liposits, Z
    Okada, H
    EUROPEAN JOURNAL OF NEUROSCIENCE, 1998, 10 : 167 - 167
  • [8] TERMINAL COMPLEMENT COMPONENTS PLAY A ROLE IN THE EXPRESSION OF C5A
    GRESHAM, HD
    RENFER, L
    HAMMER, CH
    FRANK, MM
    JOURNAL OF IMMUNOLOGY, 1987, 138 (03): : 838 - 841
  • [9] Complement C5a receptors in the pituitary gland: expression and function
    Francis, Karen
    Lewis, B. Mary
    Monk, Peter N.
    Ham, Jack
    JOURNAL OF ENDOCRINOLOGY, 2008, 199 (03) : 417 - 424
  • [10] Rational design of antibody-like peptides for targeting the human complement fragment protein C5a
    Ghosh, Manaswini
    Shadangi, Sucharita
    Rana, Soumendra
    PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2024, 92 (04) : 449 - 463